Xiuxiu Lu at Kylie Walters (she/her) lab @NCIResearchCtr NIH and colleagues the authors identify a small molecule degrader (XL44) for hRpn13 and solve the XL44-hRpn13 structure >nature.com/articles/s4146…

The Coleman family will holding a recognition event for C. Norman "Norm" Coleman, MD next Monday, April 8 in Washington, DC. If you would like to attend, please email [email protected] to receive an RSVP link and full event details.

The inaugural NIH Liquid Biopsy Conference is disease agnostic, covering many different clinical and research applications. Learn from Dr. Vinit Mahajan about using aqueous and vitreous fluid of the eye to study aging! Registration is free; sign up today! ncifrederick.cancer.gov/events/confere…

The first-ever NIH-wide conference on liquid biopsies will feature lunchtime interactive sessions on clinical implementation. Foundation Medicine's Dave Fabrizio and AstraZeneca's Diana Vega will discuss molecular residual disease! Registration is required: ncifrederick.cancer.gov/events/confere…

With a freindly environment with top-notch radiologists and colleagues by your side! @NIHRadiology

Support an Endowed ASCO YIA in #ProstateCancer in Honor of Dr. Felix Feng Click to donate: p2p.conquer.org/uniteandconque…

🔵Our group has been working on localized prostate cancer imaging for more than one and a half decades. 🔬🩻We began by optimizing MRI vs. pathology correlation using patient-specific molds. 🔷Over the years, we've developed organ segmentation and lesion detection models in

NMR enthusiasts interested in managing a biomolecular NMR facility: please consider applying your NMR talent to our NCI mission to beat cancer!! linkedin.com/jobs/view/3938…

1/2 The pros + cons of "R's of Fractionated Radiotherapy" in the new issue of IJROBP - The Red Journal #radbio ➡️Is7⃣ a good number❓ sciencedirect.com/science/articl… ➡️ Or do we need to move on from this concept❓ Our thoughts with Ismael Banla, MD PhD & William L Hwang 📢FREE PDF sciencedirect.com/science/articl…

Welcome to CCR!

Top 3 #radbio IJROBP - The Red Journal articles in 2023: Immune responses & alpha/beta 😊 🙏🙏🙏 linkinghub.elsevier.com/retrieve/pii/S… redjournal.org/article/S0360-… redjournal.org/article/S0360-… @CVanpouilleBox @lauremarignol Deborah Citrin

NCI's Prostate Cancer Multidisciplinary Clinic is a #telehealth service (at no-cost for the patient) for men newly diagnosed with localized #ProstateCancer who are seeking a second opinion and/or clinical trial opportunities. For more info ⤵️ go.nih.gov/DLiZlwG NIH

Agree, the rates of G3+ are higher than I would expect. It will be interesting to see the publication when available.

1/ #ASTRO24 📢Dr. Jason Efstathiou Mass General Cancer Center taking it away: Protons vs IMRT in #ProstateCancer 🔥🔥‼️ Sue Yom IJROBP - The Red Journal

Outstanding presentation by Dr. Jason Efstathiou #ASTRO24 showing no improvement in any outcome with proton therapy for localised prostate cancer compared to photon therapy. Congratulations to all authors! 👏

Median FU was 5 years, no difference in clinical outcomes between two groups #ASTRO24 #PARTIQoL

A randomized trial showed noninferiority of stereotactic body radiotherapy to conventionally or moderately hypofractionated radiotherapy in preventing biochemical recurrence in selected men with localized prostate cancer. Full PACE-B trial results: nej.md/3Y7coBm

With heavy hearts, we remember & honor Dr. Felix Feng. May his memory be a blessing. 💝💝💝 donate.cancer.org/g/tjjfqwdnrxrl…

SEEKING PARTICIPANTS: An NCI #ClinicalTrial is researching immunotherapy for people with #ThroatCancer. The trial will take place at the NIH Clinical Center in Maryland, and there is no cost for medical care or participation. go.nih.gov/CZrIi5z #HeadAndNeckCancer

📢Another great #radbio review in the IJROBP - The Red Journal #RedJournal Informative review on the enigmatic MYC transcription factor & potential role of MYC inhibitors for #radiotherapy‼️ Sue Yom Deborah Citrin Kristopher Sarosiek PDF 👉redjournal.org/action/showPdf… redjournal.org/article/S0360-…